ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

176 hedge funds and large institutions have $1.58B invested in Intra-Cellular Therapies Inc. in 2020 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 71 increasing their positions, 39 reducing their positions, and 20 closing their positions.

Holders
176
Holders Change
+27
Holders Change %
+18.12%
% of All Funds
3.56%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
47
Increased
71
Reduced
39
Closed
20
Calls
$38.2M
Puts
$29.7M
Net Calls
+$8.46M
Net Calls Change
-$41.4M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$304M
2
WA
2
Wasatch Advisors
Utah
$139M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$77.3M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$160M
5
TCM
5
TimesSquare Capital Management
New York
$23.2M

Top Sellers

1
SLT
1
St Louis Trust
Missouri
$0
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$8.04M
3
Goldman Sachs
3
Goldman Sachs
New York
$3.74M
4
Norges Bank
4
Norges Bank
Norway
$9M
5
BG
5
Bellevue Group
Switzerland
$91.9M
Name Market Value Shares Shares
Change 		Shares
Change %
MIM
101
MetLife Investment Management
New Jersey
$679K 26,466 – –
State Board of Administration of Florida Retirement System
102
State Board of Administration of Florida Retirement System
Florida
$667K 25,988 +4,540 +21%
IBT
103
International Biotechnology Trust
United Kingdom
$637K 24,800 +1,800 +8%
Arrowstreet Capital
104
Arrowstreet Capital
Massachusetts
$562K 21,919 +21,919 New
VOYA Investment Management
105
VOYA Investment Management
Georgia
$561K 21,857 +2,561 +13%
EAM
106
Erste Asset Management
Austria
$536K 21,000 +21,000 New
AMC
107
Asset Management Corp
Illinois
$531K 20,685 +2,750 +15%
M&T Bank
108
M&T Bank
New York
$518K 20,176 +3,071 +18%
AC
109
Amia Capital
United Kingdom
$512K 19,972 -5,630 -22%
MLICM
110
Metropolitan Life Insurance Company (MetLife)
New York
$489K 19,062 +2,610 +16%
TRCT
111
Tower Research Capital (TRC)
New York
$488K 19,044 +11,573 +155%
ProShare Advisors
112
ProShare Advisors
Maryland
$484K 18,858 +764 +4%
ASRS
113
Arizona State Retirement System
Arizona
$463K 18,045 +4,496 +33%
TD Asset Management
114
TD Asset Management
Ontario, Canada
$434K 16,916 -6,412 -27%
Group One Trading
115
Group One Trading
Illinois
$414K 16,132 -56,221 -78%
BNP Paribas Financial Markets
116
BNP Paribas Financial Markets
France
$395K 15,389 +11,845 +334%
VEA
117
Virtus ETF Advisers
New York
$393K 15,303 -2,089 -12%
LPL Financial
118
LPL Financial
California
$372K 14,495 +1,397 +11%
AWCI
119
Alpine Woods Capital Investors
New York
$364K 14,200 -1,500 -10%
Qube Research & Technologies (QRT)
120
Qube Research & Technologies (QRT)
United Kingdom
$361K 14,076 +14,076 New
Principal Financial Group
121
Principal Financial Group
Iowa
$353K 13,775 -194 -1%
BAM
122
Blueshift Asset Management
New Jersey
$345K 13,444 +13,444 New
GAM
123
Gemmer Asset Management
California
$321K 12,500 -1,000 -7%
MPCG
124
Matrix Private Capital Group
New York
$303K 11,800 -1,700 -13%
Citigroup
125
Citigroup
New York
$293K 11,432 -23,175 -67%
3 4
5
6 7